Albemarle Corporation $ALB

Materials · Specialty Chemicals · NYSE/NASDAQ

Profile updated

$95.76
+1.12 (+1.18%)
As of Oct 20, 2026, 4:10 PM EDT · cached
Price history
Loading chart…

Key facts

52-week range (closes)
$88.45 – $215.62 Lowest close Nov 4, 2025, highest Apr 16, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends
December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since
Jul 1, 2016, replacing AGL Resources (GAS) and TECO Energy (TE) · AGL Resources was acquired by Southern Company. · TECO Energy was acquired by EMA. · All S&P 500 changes

Albemarle Corporation (ALB) is trading up at $95.76 (+1.18%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Materials sector.

Albemarle Corporation revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$9.62B$4.22B−$1.18BFY2016 revenue: $2.68BFY2016 net income: $643.7M · Net margin 24.0%'16FY2017 revenue: $3.07BFY2017 net income: $54.9M · Net margin 1.8%'17FY2018 revenue: $3.37BFY2018 net income: $693.6M · Net margin 20.6%'18FY2019 revenue: $3.59BFY2019 net income: $533.2M · Net margin 14.9%'19FY2020 revenue: $3.13BFY2020 net income: $375.8M · Net margin 12.0%'20FY2021 revenue: $3.33BFY2021 net income: $123.7M · Net margin 3.7%'21FY2022 revenue: $7.32BFY2022 net income: $2.69B · Net margin 36.7%'22FY2023 revenue: $9.62BFY2023 net income: $1.57B · Net margin 16.4%'23FY2024 revenue: $5.38BFY2024 net income: −$1.18B · Net margin −21.9%'24FY2025 revenue: $5.14BFY2025 net income: −$510.6M · Net margin −9.9%'25−9.2%0%20%40%60%FY2016 net margin: 24.0%FY2017 net margin: 1.8%FY2018 net margin: 20.6%FY2019 net margin: 14.9%FY2020 net margin: 12.0%FY2021 net margin: 3.7%FY2022 net margin: 36.7%FY2023 net margin: 16.4%FY2024 net margin: −21.9% (off the scale, which stops at −9.2%)FY2025 net margin: −9.9% (off the scale, which stops at −9.2%)
Albemarle Corporation annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$2.68B$3.07B$3.37B$3.59B$3.13B$3.33B$7.32B$9.62B$5.38B$5.14B
Growth (year over year)−5.3%+14.7%+9.9%+6.4%−12.8%+6.4%+120.0%+31.4%−44.1%−4.4%
Gross profit$970.3M$1.11B$1.22B$1.26B$994.9M$998.0M$3.07B$1.19B$62.5M$668.7M
Gross margin36.2%36.0%36.1%35.0%31.8%30.0%42.0%12.3%1.2%13.0%
Operating income$601.0M$571.7M$911.5M$666.1M$505.8M$798.4M$2.47B$251.9M−$1.78B−$367.1M
Operating margin22.4%18.6%27.0%18.6%16.2%24.0%33.7%2.6%−33.0%−7.1%
Net income$643.7M$54.9M$693.6M$533.2M$375.8M$123.7M$2.69B$1.57B−$1.18B−$510.6M
Net margin24.0%1.8%20.6%14.9%12.0%3.7%36.7%16.4%−21.9%−9.9%
EPS (diluted)$5.68$0.49$6.34$5.02$3.52$1.06$22.84$13.36−$11.20−$5.76
Balance sheet
Cash and equivalents$2.27B$1.14B$555.3M$613.1M$746.7M$439.3M$1.50B$889.9M$1.19B$1.62B
Total assets$8.16B$7.75B$7.58B$9.86B$10.5B$11.0B$15.5B$18.3B$16.6B$16.4B
Total liabilities$4.22B$3.93B$3.82B$5.77B$5.98B$5.17B$7.27B$8.61B$6.41B$6.59B
Long-term debt$2.12B$1.42B$1.40B$2.86B$2.77B$2.00B$3.21B$3.54B$3.12B$3.12B
Shareholders' equity$3.80B$3.67B$3.59B$3.93B$4.27B$5.63B$7.98B$9.41B$9.96B$9.53B
Cash flow
Operating cash flow$735.5M$304.0M$546.2M$719.4M$798.9M$344.3M$1.91B$1.33B$687.9M$1.28B
Capital expenditure$196.7M$317.7M$700.0M$851.8M$850.5M$953.7M$1.26B$2.15B$1.68B$589.8M
Free cash flow$538.9M−$13.7M−$153.8M−$132.4M−$51.6M−$609.4M$646.2M−$828.0M−$992.7M$692.5M
Dividends paid$135.4M$140.6M$144.6M$152.2M$161.8M$177.9M$184.4M$187.2M$188.5M$190.5M
Share buybacks$0$250.0M$500.0M$0$0—————

From Albemarle Corporation's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Albemarle Corporation vs the Materials sector and the S&P 500

Albemarle Corporation's latest reported figures next to the median of the other 24 S&P 500 Materials companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Albemarle Corporation compared with the median Materials company and the median S&P 500 company
MeasureAlbemarle CorporationMaterials (24 other S&P 500 companies)S&P 500 (502 other companies)
Revenue growth, latest fiscal year−4.4%+4.4%+7.0%
Net margin, latest fiscal year−9.9%7.3%13.0%
Dividend per share, latest fiscal year$1.62$2.21$2.40
Share price change, 1 year−1.6%+13.2%+5.9%

Albemarle Corporation: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Albemarle Corporation included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 24/496, net margin 24/496, dividend per share 23/349, 1-year price change 24/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 23 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About Albemarle Corporation

Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024.

Source: Wikipedia — Albemarle Corporation

Headquarters
Charlotte, North Carolina From SEC filings, Oct 2026

Company profile

Albemarle Corporation, a Virginia corporation headquartered at 4250 Congress Street, Suite 900, in Charlotte, North Carolina, describes its business in its 10-K as transforming essential resources into critical ingredients for mobility, energy, connectivity and health. Its fiscal year ends December 31 and its common stock, $.01 par value, trades on the New York Stock Exchange as ALB; 117,847,220 shares were outstanding on February 4, 2026 (10-K cover), and 118,005,057 on July 29, 2026 (10-Q cover). The 10-K reports approximately 7,800 employees at December 31, 2025, including employees of consolidated joint ventures. For 2025 it reported three segments: Energy Storage, which makes basic lithium compounds including lithium carbonate and lithium hydroxide; Specialties, covering bromine and highly specialized lithium solutions; and Ketjen, its catalysts segment. After selling control of the Refining Solutions business in March 2026, its 10-Q for the quarter ended June 30, 2026 reports two segments, Energy Storage and Specialties.

The 10-K shows large swings. Revenues were $5,142,733 thousand in 2025 and $5,377,526 thousand in 2024, against net sales of $9,617,203 thousand in 2023 and $7,320,104 thousand in 2022. Net loss attributable to Albemarle Corporation common shareholders was $677,378 thousand in 2025, or $5.76 per diluted share, and $1,316,096 thousand in 2024, or $11.20; in 2023 net income attributable to common shareholders was $1,573,476 thousand, or $13.36 per diluted share. The 2025 operating loss of $367,084 thousand includes a goodwill impairment of $181,070 thousand and long-lived asset impairment charges of $245,600 thousand, both recorded in connection with the sale of its Refining Solutions business; the 2024 operating loss of $1,776,545 thousand includes restructuring charges and asset write-offs of $1,134,316 thousand, from 2024 restructuring actions that included stopping construction of Kemerton Train 3 and indefinitely suspending Train 4 in Western Australia (10-K).

According to its 10-Q for the quarter ended June 30, 2026 (unaudited), net sales were $1,743,313 thousand for the second quarter, against $1,329,992 thousand a year earlier, and net income attributable to Albemarle Corporation common shareholders was $438,272 thousand, or $3.72 per basic share, against a loss of $18,790 thousand, or $0.16 per share. In its August 5, 2026 release Albemarle attributed the increase in net sales primarily to higher prices in both Energy Storage and Specialties and volume growth in Specialties. J. Kent Masters is Chairman, President and Chief Executive Officer and Neal R. Sheorey is Executive Vice President and Chief Financial Officer (10-Q, Exhibits 31.1 and 31.2). In a Form 8-K filed September 3, 2026, Albemarle said its board had approved a succession plan under which Ragnar Udd, Chief Commercial Officer of BHP, is to become President and CEO effective February 1, 2027 or a mutually agreed earlier date, with Mr. Masters becoming Executive Chair.

Summary sources:1234567891011121314151617

$5,142,733 thousand8
Revenues, 2025 (year ended December 31, 2025)
$668,719 thousand8
Gross profit, 2025
$181,070 thousand8
Goodwill impairment, 2025
$245,600 thousand8
Long-lived asset impairment charges, 2025
$(367,084) thousand8
Operating loss, 2025
$243,744 thousand8
Equity in net income of unconsolidated investments (net of tax), 2025
$(677,378) thousand8
Net loss attributable to Albemarle Corporation common shareholders, 2025
$(5.76)8
Diluted loss per share attributable to common shareholders, 2025
$(1,316,096) thousand8
Net loss attributable to Albemarle Corporation common shareholders, 2024
$1,134,316 thousand8
Restructuring charges and asset write-offs, 2024
$1,282,267 thousand18
Net cash provided by operating activities, 2025
$589,801 thousand18
Capital expenditures, 2025
$1,680,529 thousand18
Capital expenditures, 2024
$190,530 thousand18
Dividends paid to common shareholders, 2025
$1.6219
Cash dividends declared per share, 2025
$1,618,001 thousand20
Cash and cash equivalents, December 31, 2025
$16,374,211 thousand20
Total assets, December 31, 2025
$3,119,464 thousand20
Long-term debt, December 31, 2025
$9,781,461 thousand20
Total equity, December 31, 2025
7,8002
Employees, December 31, 2025 (approximate, including consolidated joint ventures)
118,005,05711
Common shares outstanding, July 29, 2026
$1,743,313 thousand12
Net sales, quarter ended June 30, 2026 (unaudited)
$3,172,044 thousand12
Net sales, six months ended June 30, 2026 (unaudited)
$438,272 thousand12
Net income attributable to Albemarle Corporation common shareholders, quarter ended June 30, 2026 (unaudited)
$3.7212
Basic earnings per share attributable to common shareholders, quarter ended June 30, 2026 (unaudited)
$3.5221
Diluted earnings per share attributable to common shareholders, quarter ended June 30, 2026 (unaudited)
$858 million14
Adjusted EBITDA, quarter ended June 30, 2026 (non-GAAP, as reported by Albemarle)
$3.7514
Adjusted diluted EPS, quarter ended June 30, 2026 (non-GAAP, as reported by Albemarle)
$1,056,241 thousand22
Net cash provided by operating activities, six months ended June 30, 2026 (unaudited)
$525,156 thousand22
Proceeds from sale of businesses, net of cash sold, six months ended June 30, 2026 (unaudited)
$0.40523
Cash dividends declared per share, quarter ended June 30, 2026 (unaudited)
$1,802,107 thousand24
Long-term debt, June 30, 2026 (unaudited)
$15,905,095 thousand24
Total assets, June 30, 2026 (unaudited)
approximately $500 million14
Full-year 2026 capital expenditures (company outlook, August 5, 2026)

Revenue by fiscal year, as reported in 10-K

Fiscal yearRevenue (as reported in 10-K)Reported asFiled
2021$3,327,957 thousand4Form 10-K for fiscal year 2021 (year ended December 31, 2021), net sales, in thousands as filedFeb 22, 2022
2022$7,320,104 thousand5Form 10-K for fiscal year 2022 (year ended December 31, 2022), net sales, in thousands as filedFeb 15, 2023
2023$9,617,203 thousand6Form 10-K for fiscal year 2023 (year ended December 31, 2023), net sales, in thousands as filedFeb 15, 2024
2024$5,377,526 thousand7Form 10-K for fiscal year 2024 (year ended December 31, 2024), revenues, in thousands as filedFeb 12, 2025
2025$5,142,733 thousand8Form 10-K for fiscal year 2025 (year ended December 31, 2025), revenues, in thousands as filedFeb 11, 2026

Segments and products

Risks

Frequently asked questions

What does Albemarle do?
Albemarle is a Charlotte, North Carolina based producer of lithium and bromine. For 2025 its 10-K reports three segments: Energy Storage (basic lithium compounds such as lithium carbonate and lithium hydroxide), Specialties (bromine and highly specialized lithium solutions) and Ketjen (its catalysts segment). After the March 2026 sale of control of Refining Solutions, its 10-Q reports two segments, Energy Storage and Specialties.
How much revenue did Albemarle make in 2025?
Revenues were $5,142,733 thousand in 2025, against $5,377,526 thousand in 2024, according to its 10-K. Net sales were $9,617,203 thousand in 2023 and $7,320,104 thousand in 2022, as filed in those years' 10-Ks.
Did Albemarle make a profit in 2025?
No. Its 10-K reports a net loss attributable to Albemarle Corporation common shareholders of $677,378 thousand in 2025, or $5.76 per diluted share, after a goodwill impairment of $181,070 thousand and long-lived asset impairment charges of $245,600 thousand. In 2024 the net loss attributable to common shareholders was $1,316,096 thousand, or $11.20 per diluted share.
Which Albemarle segment is the largest?
Energy Storage, with 2025 net sales of $2,710,035 thousand and segment adjusted EBITDA of $697,215 thousand. Specialties had net sales of $1,366,435 thousand and adjusted EBITDA of $275,739 thousand, and Ketjen $1,066,263 thousand and $150,398 thousand (10-K, segment details).
What were Albemarle's latest quarterly results?
For the quarter ended June 30, 2026, its 10-Q (unaudited) reports net sales of $1,743,313 thousand, against $1,329,992 thousand a year earlier, and net income attributable to Albemarle Corporation common shareholders of $438,272 thousand, against a loss of $18,790 thousand. Diluted earnings per share attributable to common shareholders were $3.52. The August 5, 2026 release reports adjusted EBITDA of $858 million and adjusted diluted EPS of $3.75, both non-GAAP measures.
What is Albemarle's outlook for 2026?
In its August 5, 2026 release Albemarle said it expects full-year 2026 capital expenditures of approximately $500 million, and gave its 2026 net sales and adjusted EBITDA outlook as a table of outcomes under recently observed lithium market price scenarios. These are the company's own projections, not reported results.
Does Albemarle pay a dividend?
Yes. Cash dividends declared were $1.62 per share in 2025 and dividends paid to common shareholders totaled $190,530 thousand (10-K). Cash dividends declared were $0.405 per share for the quarter ended June 30, 2026 (10-Q).
Who runs Albemarle?
J. Kent Masters is Chairman, President and Chief Executive Officer and Neal R. Sheorey is Executive Vice President and Chief Financial Officer; both certified Albemarle's 10-Q for the quarter ended June 30, 2026. A Form 8-K filed September 3, 2026 says Ragnar Udd is to become President and CEO effective February 1, 2027 or a mutually agreed earlier date, with Mr. Masters becoming Executive Chair.

Sources

  1. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Cover (XBRL financial report R1), Feb 11, 2026
  2. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025 (Items 1 Business and 1A Risk Factors), Feb 11, 2026
  3. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Segment and Geographic Area Information note (XBRL financial report R35), Feb 11, 2026
  4. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2021: Consolidated Statements of Income (XBRL financial report R2), Feb 22, 2022
  5. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2022: Consolidated Statements of Income (XBRL financial report R2), Feb 15, 2023
  6. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2023: Consolidated Statements of Income (XBRL financial report R3), Feb 15, 2024
  7. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2024: Consolidated Statements of Income (XBRL financial report R3), Feb 12, 2025
  8. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Consolidated Statements of Income (XBRL financial report R3), Feb 11, 2026
  9. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Divestitures note (XBRL financial report R12), Feb 11, 2026
  10. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Restructuring Charges and Asset Write-Offs note (XBRL financial report R27), Feb 11, 2026
  11. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Cover (XBRL financial report R1), Aug 5, 2026
  12. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Consolidated Statements of Loss (XBRL financial report R2), Aug 5, 2026
  13. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Segment Information note (XBRL financial report R27), Aug 5, 2026
  14. Albemarle Corporation (SEC filing), Albemarle Corporation Form 8-K, Item 2.02, Exhibit 99.1: Albemarle Reports Second Quarter 2026 Results, Aug 5, 2026
  15. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026, Exhibit 31.1: certification of the Chairman, President and Chief Executive Officer, Aug 5, 2026
  16. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026, Exhibit 31.2: certification of the Executive Vice President and Chief Financial Officer, Aug 5, 2026
  17. Albemarle Corporation (SEC filing), Albemarle Corporation Form 8-K, Item 5.02: Chief Executive Officer succession (event date September 2, 2026), Sep 3, 2026
  18. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Consolidated Statements of Cash Flows (XBRL financial report R10), Feb 11, 2026
  19. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Consolidated Statements of Changes in Equity (Parenthetical) (XBRL financial report R9), Feb 11, 2026
  20. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Consolidated Balance Sheets (XBRL financial report R6), Feb 11, 2026
  21. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Earnings Per Share note (XBRL financial report R22), Aug 5, 2026
  22. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Condensed Consolidated Statements of Cash Flows (XBRL financial report R8), Aug 5, 2026
  23. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Consolidated Statements of Changes in Equity (Parenthetical) (XBRL financial report R7), Aug 5, 2026
  24. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Condensed Consolidated Balance Sheets (XBRL financial report R4), Aug 5, 2026
  25. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Segment and Geographic Area Information - Summarized Financial Information by Reportable Segments (Details) (XBRL financial report R138), Feb 11, 2026
  26. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Segment Information - Summarized Financial Information by Reportable Segments (Details) (XBRL financial report R87), Aug 5, 2026
  27. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Restructuring Charges and Asset Write-Offs note (XBRL financial report R19), Aug 5, 2026
  28. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-Q for the quarter ended June 30, 2026: Divestitures note (XBRL financial report R11), Aug 5, 2026
  29. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Commitments and Contingencies note (XBRL financial report R25), Feb 11, 2026
  30. Albemarle Corporation (SEC filing), Albemarle Corporation Form 10-K for the fiscal year ended December 31, 2025: Cybersecurity Risk Management and Strategy Disclosure (XBRL financial report R38), Feb 11, 2026

Figures last checked against the sources above on . General information, not investment advice.

Recent News (19)

More Materials stocks

Browse all companies →